| Literature DB >> 35694188 |
Minky Mukhija1, Bhuwan Chandra Joshi2, Partha Sarathi Bairy3, Anurag Bhargava1, Archana N Sah2.
Abstract
Background: Cancer is considered as the second deadliest disease globally. Plants have continuously offered unique secondary metabolites with remarkable biological applications. Lignans have gained great importance due to their biological activity. Previous studies revealed that the most remarkable bioactivity of lignan class of molecules is anticancer. They are derived from the oxidative dimerization of two phenylpropanoid units. This review covers the isolated anticancer lignans and their mechanistic aspects. Main body: A bibliographic investigation was performed by analyzing the information available on anticancer lignans in the internationally accepted scientific databases including Web of Science, SciFinder, PubMed, Scopus, and Google Scholar. In this review we have tried to sum up the isolated anticancerous lignan, its source, active plant part, extract and various cell lines used to establish different studies. Here we have included a total number of 113 natural lignans. Many studies that mainly performed in human cell lines have reported. Very few plants have been evaluated for their in vivo anticancer activity.Entities:
Keywords: Anticancer plants; Cytotoxicity; Lignan; Podophyllotoxin
Year: 2022 PMID: 35694188 PMCID: PMC9166195 DOI: 10.1186/s43088-022-00256-6
Source DB: PubMed Journal: Beni Suef Univ J Basic Appl Sci ISSN: 2314-8535
Fig. 1a Global cancer cases distribution types including all age groups of females. Source: GLOBOCAN, 2020. b Global cancer cases distribution types including all age groups of males. Source: GLOBOCAN, 2020
Fig. 2a Phenylpropane unit. b Dimer of C6-C3 unit via β-β′ bonding
Fig. 3Eight chemical classes of lignan molecules
List of lignans isolated from plant with anticancer activity
| Name | Structure ID (Fig. | Source | Extract | Part | Cancer cell line used (in vitro) | IC50 | In vivo | Dose | Comments | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| 9-OH-Pinoresinol | 1 | Chloroform fraction of ethanolic extract | Aerial parts | L5178Y | – | – | 10 μg/mL | Ethanolic extract of the plant reduced the growth of leukemia mouse lymphoma cells to 23.8%. It looks like lignan 9-OH-pinoresinol is responsible for the activity which is well known from other plant sources | [ | |
| Anhydrosecoisolariciresinol | 2 | – | Seeds | MCF-7 | 100 µM | The isolated lignan causes 30% inhibition of cell growth as compared to control | [ | |||
| 4-O-(2′,3′,4′-tri-O-methyl-β-D-xylopyranosyl) diphyllin | 3 | – | Aerial parts | HCT116 | 0.08 ± 0.03 µM | In vitro studies has been shown to inhibit the growth of a number of cancer cell | [ | |||
| ( +)-Hinokinin | 4 | Methanol | Stems and roots | P-388 | 1.54 µg/mL (ED50) | Showed significant cytotoxic activity | [ | |||
| Vitexin | 5 | Ethanol | Seeds | MCF-7, ZR-75-1, SK-BR-7, MDA-MB-231, MDA-MB-435s, PC-3, LNCaP and COC1 | 100 mg/kg | In vivo studies done using tumor xenograft models like MCF-7, MA782, MDA-MB-435s, and T47D xenografts for breast, PC-3 for prostate, HeLa cells for cervical, and HepG2 for liver xenograft | Vitexins (lignan mixture) has cytotoxic effects on MCF-7, ZR-75-1, SK-BR-7, MDA-MB-231, MDA-MB-435s, PC-3, LNCaP COC1 cancer cells. Vitexin induced antitumor effect and cytotoxic activity is exerted through proapoptotic process, which is mediated by a decreased Bcl-2/Bax ratio and activation of caspases | [ | ||
| 7-Hydroxymatairesinol (HMR) | 6 | Acetone–water (9:1) | Heartwood | LNCaP human prostate cancer xenografts in athymic nude male mice | There is significant decrease in tumor volume. A control diet supplemented with 0.15% or 0.30% of HMR was administered to mice and the tumor take rate and growth was observed for 9 weeks. The diet supplemented with HMR has been shown to inhibit the growth of LNCaP tumors. Mice treated with HMR had smaller tumor volume, lower tumor take rate, increased proportion of non-growing tumors, and higher tumor cell apoptotic index compared with controls. Cell proliferation index was also decreased in mice receiving the 0.30% HMR diet when compared with mice receiving the control diet | [ | ||||
| 6′-Hydroxy justicidin A, 6′-hydroxy justicidin B, justicidin B | 7, 8, 9 | Ethanolic | Whole plant | K562 | 20, 43.9 and 45.4 µM | All the compounds significantly inhibited the growth of K562 cells by decreasing both proliferation and SOD activity and inducing apoptosis in dose-dependent manner. Activation of caspase-3 pathway suggests that these compounds induce apoptosis through caspase intrinsic or extrinsic pathway | [ | |||
| Picropolygamain, Burseranin | 10, 11 | Methanol | Stem | HT1080 | 1.9, 5.5 µg/mL (ED50) | Showed significant cytotoxic activity | [ | |||
| (-)-Deoxypodophyllotoxin, (-)-yatein | 12, 13, | Methanol | Bark | P-388, KB16, A549, HT-29 | < 1 µg/mI (ED50) | Showed significant cytotoxic activity | [ | |||
| Hanultarin, 1,4-O-Diferuloylsecoisolariciresinol | 14, 15 | 80% Aqueous methanol | Seeds | A549, SK-Mel-2, B16F1 | 3–13 µg/mL | Inhibitory effect on the polymerization of the actin cytoskeleton in normal epidermal keratinocyte (HaCaT cells) has been shown by compound Hanultarin as compared to those of the other isolates | [ | |||
| Phyllanthusmin A | 16 | Chloroform fraction of methanolic extract | Stems and roots | KB and P-388 | 2.24 µg/mL and 0.13 µg/mL | Showed significant cytotoxic activity | [ | |||
| Cleistanthin A, Cleistanthin A methyl ether, Taxodiifoloside | 17, 18, 19 | Ethanol fraction of methanol extract | Aerial parts | Five cultured mammalian cell lines. P-388, KB, Col-2, MCF-7 and Lu-1 | Compounds showed GI50 value in the range 10–6–10–9 M | Cleistanthin A, Cleistanthin A methyl ether has shown potent cytotoxic activity and Taxodiifoloside showed moderate activity | [ | |||
| 5-Methoxy-4-epipodophyllotoxin, 5-methoxypodophyllotoxin | 20, 21 | Ethyl acetate | Bark | KB | 45 µM and 11 µM | Both isolated lignans were also evaluated for their tubulin assembly inhibitory activity. 5-methoxy-4-epipodophyllotoxin inhibited the assembly of tubulin into microtubules with an IC50 of 9 µM, whereas the IC50 of 5-methoxypodophyllotoxin was 5 µM | [ | |||
| Propinquanin B | 22 | Chloroform | Stems | HL-60, Hep-G2, R- Hep-G2, KB, Bel-7402 | 7.15, 9.81, 14.00, 11.70, 18.81 µM | Cell cycle study and Hoechst 33,258 staining assay suggests that cytotoxic activity of compound may be due to induction of apoptosis | [ | |||
Beilschmin A, Beilschmin B, Beilschmin C | 23, 24, 25 | - | Stems | P-388 and HT-29 | 1.2 and 5.0 µg/mL 2.2 and 5.1 µg/mL 3.6 and 10.5 µg/mL | Showed significant cytotoxic activity | [ | |||
| Magnolignan A 2-O-β-D-glucopyranoside, Strebluslignanol | 26, 27 | Chloroform fraction of 75% ethanol | Heartwood | Hep-2 and Hep-G2 | 13.3 μM, 46.4 μM and 10.1 μM, 21.7 μM | Both lignans showed medium cytotoxic activity | [ | |||
| Erlangerin A to D | 2, 29, 30, 31 | Resin | EAhy926 and HeLa, L929 and RAW 264.7 | 68 ± 6, 40 ± 5, 90 ± 5 and 44 ± 9 µg/mL (EC50) 23 ± 1.4, 4.0 ± 1.4, 68 ± 6 and 28 ± 0.3 (EC50) 0.16 ± 0.09, 0.55 ± 0.007, 5.6 ± 1.5 (EC25), and 0.97 ± 0.21 µg/mL (EC50) 0.026 ± 0.007, 0.026 ± 0.009, 3.5 ± 1 µg/mL(EC25), 0.11 ± 0.017 µg/mL (EC50) | Erlangerins C and D were similar to podophyllotoxin on the basis of their structure and biological activity so may have same mechanism of action. They induced a concentration-dependent cytotoxicity in RAW 264.7 and cytostatic effect in HeLa, EAhy926, and L929 cells. But Erlangerins A and B suppressed cell viability at relatively higher concentrations when compared with Erlangerin C and D | [ | ||||
Machilin A, (-)-Sesamin, Machilin G, ( +)-Galbacin | 32, 33, 34, 35 | Dichloromethane | Bark | HCT-15, MCF-7 and A549 | 12.4, 12.4 and 7.9 µM 4.4, 3.4 and 11.0 µM 1.4, 2.7 and 8.3 µM 6.2, 7.9 and 7.9 µM | PLCγ1 plays a key role in proliferation and progression of human cancer. These compounds inhibit PLCγ1 and showed strong antiproliferative activity | [ | |||
| Enterolactone, Enterodiol | 36, 37 | Mammalian lignans | LNCaP | 57 mM and 100 mM | 10–100 microM | Growth of prostate cancer cells were suppressed may be by hormonally dependent and independent mechanisms | [ | |||
| Matairesinol | 38 | – | Seeds | HL-60 | 60 μM | DNA content histogram was analyzed by flow cytometry and it showed rapid increase in subdiploid cells and a concomitant decrease in diploid cells exposed to 100 μM matairesinol. It was concluded that cell death was due to the DNA damage and apoptosis | [ | |||
| Nordihydroguaiaretic acid | 39 | Resinous exudate | Bush | SW480 | 1.9 ± 0.5 µg | It caused time and dose-dependent loss of mitochondrial membrane potential (MMP), down regulation of the anti-apoptotic protein bclxl and an increase of the apoptotic index. It also induced a shift of the culture population to the G2/M phase of the cell cycle | [ | |||
| Epiashantin | 40 | – | Warmwood | SW480 | 9.8 ± 4.5 µM | The compound caused a time and dose-dependent loss of mitochondrial membrane potential (MMP), down regulation of the anti-apoptotic protein bclxl and an increase of the apoptotic index | [ | |||
| Arctigenin | 41 | – | Root | SW480 | 16.5 ± 8.5 µM | The compound caused a time and dose-dependent loss of mitochondrial membrane potential (MMP), down regulation of the anti-apoptotic protein bclxl and an increase of the apoptotic index | [ | |||
| 7′-Hydroxy-3′,4′,5,9,9′-pentamethoxy-3,4-methylene dioxylignan | 42 | Ethyl acetate | Whole plant | HEp-2 | 4.46 µM | 7′-hydroxy-3′,4′,5,9,9′-pentamethoxy-3,4-methylene dioxylignan was capable of inhibiting telomerase activity and also could inhibit bcl2 and activate caspase 3 and caspase 8 whose significance in the induction of apoptosis is well known | [ | |||
| ( +)-7′-Acetylpicropodophyllin, Epiyangambin | 43, 44 | Ethyl acetate | Twigs | JB6 | 0.15 and 0.4.2 µg/mL | Significant inhibition of the transformation of murine epidermal JB6 cells, | [ | |||
Deoxypodophyllotoxin, 6,7 Demethylenedeoxypodophyllotoxin, 1,2,3,4-Dehydrodeoxypodophyllotoxin, Dehydropodophyllotoxin, Bursehernin, Podorhizol, Epimagnolin | 12, 45, 46, 47, 48, 49, 50 | Seeds | Epstein-Barr virus early antigen activation (EBV-EA) induced by 12-O tetradecanoylphorbol 13-acetate (TPA) in Raji cells | 550 mol ratio/32 pmol TPA, 510 520 470 470 480 590 | Inhibitory effects on EBV activation has been shown by all isolated compounds | [ | ||||
Arctiin, Arctigenin | 51, 41 | Methanol | Aerial parts | Two stage skin carcinogenesis model using DMBA (7,12-dimethylbenz[a]anthracene) and TPA (12-O-tetradecanoyl phorbol-13-acetate) | Both lignans arctiin and arctigenin exhibited a significant inhibitory effect on the tumor promotion induced by DMBA and TPA by both topical application and oral administration. When both compounds were administered orally reduction in papillomas per mouse at 15 weeks of promotion in case of arctigenin was 4.2 ± 0.1 and Arctiin 4.0 ± 0.2, and at 20 weeks of promotion arctigenin was 6.1 ± 0.1 and Arctiin was 6.1 ± 0.2 | [ | ||||
| Elenoside | 52 | Ethanolic | Leaves | CCRFCEM, K-526, MOLT-4, RPMI-8226 | 79–97% growth inhibition | 10–4 M | Elenoside was cytotoxic to leukemic cell lines (CCRFCEM, K-526, MOLT-4, RPMI-8226) at a concentration of 10–4 M (79–97% growth inhibition). Elenoside does not show significant activity at concentration less than 10–4 | [ | ||
| Secoisolariciresinol diglycoside | 53 | Ethanolic | Seeds | Female Sprague–Dawley rats | 2.93 mmoles/g | Increased plasma insulin-like growth factor I (IGF-I) concentrations are associated with increased breast cancer risk. Secoisolariciresinol diglycoside reduced plasma IGF-I levels. It inhibit Mammary tumor development in rats | [ | |||
Phillygenol Phillyroside Phillygenoldiglycoside | 54, 55, 56 | SMMC-7721, HeLa, V79, B16 | Phillygenol has shown strong cytotoxic activity on the tested cell lines whereas Phillyroside and Phillygenoldiglycoside had little effect on the proliferation of the tested cell lines | [ | ||||||
| Podophyllotoxins | small-cell lung cancer (SCLC) dose: > 1 µg/mL (etoposide) | Disrupt the organization of the karyokinetic spindle single-strand and double-strand breaks in DNA through their interactions with DNA topoisomerase II induce cell cycle arrest in the G2-phase of the cell cycle | [ | |||||||
Ariensin Burseran Dihydroclusin diacetate | 57, 11, 58 | Methanol | Resin obtained from the bark of the plant | RAW264.7, M12.C3.F6 murine cancer cell line (macrophages transformed by virus Abelson leukemia) | 9.8, 0.4, 0.2 μM for all three isolated compounds in RAW264.7 and 2.5 μM for Dihydroclusin diacetate in M12.C3.F6 | Dihydroclusin diacetate was shown to be active against both murine cancer cell lines while ariensin, burseran, were active against only RAW246.7 murine cell line only | [ | |||
| (-)-Hinokinin | 4 | Methanol | Stem Bark | HT-29 cell line | 3.52 µg/mL (ED50 value) | Showed significant cytotoxic activity against HT-29 cell line | [ | |||
(-)-Deoxypodophyllotoxin, Angeloylpodophyllotoxin, Deoxypicropodophyllotoxin, Picropodophyllotoxin | 12, 59, 60, 61 | Methanol | Roots | HL-60 | Compounds have an apoptosis-inducing effect in HL-60 cells and it was determined by caspase-3 activation and DNA fragmentation. Typical ladders of DNA fragmentation were observed when treated with compound angeloylpodophyllotoxin, picropodophyllotoxin at 1 mM and (-)-Deoxypodophyllotoxin at 0.01 mM | [ | ||||
| Phyllanthusmin A | 62 | Chloroform fraction of methanol extract | Stems and roots | KB and P-388 | 2.24 and 0.13 µg/mL | Phyllanthusmin A showed significant cytotoxicity | [ | |||
| (-)-Kusunokinin | 63 | Dichloromethane | Fruits | MCF-7 and MDA-MB-468 | 1.18 and 1.62 µg/mL | This compound induced cell apoptosis and drove cells toward the G2/M phase which is determined by cell studies. It also decreases topoisomerase II and Bcl-2. There is increase in p53, p21, bax, cytochrome c, and caspase-8, -7, and -3 activities, except caspase-9. This shows that kusunokinin has potent anticancer activity through the extrinsic pathway and G2/M phase arrest | [ | |||
| Yatein | 13 | Methanol | Heartwood | P3X63-Ag8.653 | Yatein exhibited potent cytotoxicity, inducing 75% cell death at 25 mg/mL after 24 h of treatment | Yatein showed toxicity in P3X cells in a dose-dependently. In cells that survived to yatein treatment, the microtubular apparatus was altered, as determined by immunofluorescence techniques, and SEM and TEM analyses displayed changes in morphological and ultrastructural level. There was alteration in cell shape and membrane system was damaged | [ | |||
(-)-Carinol, (-)-Carissanol, and (-)-Nortrachelogenin | 64, 65, 66 | Methanol | Stem | MCF7 and A549 | < 1 µg/mL 11.0 and 17.4 µg/mL 29.0 and 88.3 µg/mL | The most active lignan was (-)-carinol and (-)-carissanol was more potent than (-)-nortrachelogenin | [ | |||
Sesamin, Kobusin, 4′O Demethyl magnolin | 67, 68 | Petroleum ether | Stem bark | A549 and MIA-PaCa | 37.46 ± 1.097 and 34.04 ± 1.7621 34.71 ± 2.331 and 32.86 ± 2.0271 26.47 ± 1.871 and 26.47 ± 1.871 mg/mL | Cytotoxic activity has been shown by all three isolated lignans in different ranges. 4′O dimethyl magnolin was the novel bioactive compound from a plant source and found to be most active. In apoptosis study, treatment caused typical apoptotic morphological changes. It enhances the apoptosis at IC50 dose (21.72 mg/mL) on MIA-PaCa cell line. This compound induce apoptosis as the mechanism of cell death | [ | |||
| Justirumalin | 69 | MCF-7, AGS | 42.8 and 42.1%, inhibition, respectively | 25 μg/mL | Justirumalin inhibited human stomach and breast cancer cells | [ | ||||
Justicidin E, Simplexolin | 70 | MCF-7, SF-268, CNS, NCI-H460, HCT-116 and AGS | 25 μg/mL | Justicidin E inhibited the proliferation of lung, breast and colon cancer cell lines with inhibition values ranged between 40 and 53% and simplexolin gave 40–50% inhibition against lung, breast, colon, and CNS cancer cell lines when tested at 25 µg/mL | [ | |||||
| Sylvatesmin | 72 | Methanol | Whole plant | B16, SMMC-7721, Hela | 40.4 ± 1.4 mg/mL, 113.4 ± 2.16 mg/mL, 127.9 ± 3.20 mg/mL | 25 µg/mL | Sylvatesmin exhibited the effective antitumor activity, especially on B16 cells | [ | ||
| Gomisin N | 73 | Baill., Schisandraceae or Magnoliaceae | Dichloromethane | Ripe berries | HT-29 | 43 µM | Effective against colorectal proliferative processes | [ | ||
| Epieudesmin | 74 | CH3OH/CH2Cl2 (1:1) extract | Fruits | A549, MCF-7 and HER2, MDA-MB-231 | 5.7 µM, 8.1 µM, 231 8.2 µM | Compounds displayed significant anti proliferative activity | [ | |||
| Podophyllotoxins, Diphyllin, Etoposide (VP–16), teniposide | 12, 75, 76, 77 | Whole plant | P-388, HT-29, A-549 and MEL-28 | This bioactive lignan is very effective on small cell lung cancer, malignant lymphoma, and testicular carcinoma It is also potent on Wilms tumors, ovarian cancer, brain tumors, urinary tract cancer, etc. | [ | |||||
| Liriodendrin | 78 | Water soluble fraction of methanolic extract | Stem bark | P-388 murine lymphocytic leukemia and human cancer cell types (fibrosarcoma, melanoma, breast, lung, colon and KB) | P-388—2.4 µg/mL Fibrosarcoma—98.9 µg/mL Melanoma—19 µg/mL Breast cancer—30 µg/mL Lung cancer—6.0 µg/mL Colon cancer—16 µg/mL KB—6.0 µg/mL (ED50 values) | Exhibit cytotoxic activity | [ | |||
5- Methoxydehydro podophyllotoxin, dehydro-β-peltatin methyl ether, Dehydropodophyllotoxin, Deoxydehydropodophyllotoxin, Yatein, 4′-Demethyldeoxypodophyllotoxin, Isodeoxypodophyllotoxin, Deoxypicropodophyllin, β-apopicropodophyllin | 79, 80, 47, 81, 13, 82, 83, 60, 84 | Chloroform | Aerial parts | P-388, HT-low, KB, A43l, ZR-75-1, LNCaP and U373 | 4.0, 15.6, 6.0, 6.2, > 20, 11.6 and 16.3 µg/mL 1.8, 3.4, 2.2, > 20, > 20, 3.2, and 5.9 µg/mL > 5, 9.7, 5.0, > 20, > 20, 11.7 and > 20 µg/mL > 5, > 20, 11.4, 6.2, > 20, 11.6 and > 20 µg/mL 0.4, 0.07, 0.08, > 20, 0.5, 0.16, and 0.3 µg/mL 0.005, 0.01, 0.01, 0.08, 2.1, 0.02 and 0.1 µg/mL > 20, 10.7, 6.7, 6.2, 13.2, 12.0 and 2.9 µg/mL 0.1, 0.2, 0.1, > 20, 0.6, 0.2 and 0.1 µg/mL 0.002, 0.003, 0.05, 4.3, 2.0, 0.01 and 0.001 µg/mL. (ED50 values) | [ | ||||
| Wikstromol | 85 | Chloroform fraction of ethanolic extract | Whole plant | P-388 Iympho cyticleukemia (3PS) test system | 16, 10, 4, 2, and 1 mg/kg | Wikstromol demonstrate activities of 154, 146, 137, 141, and 130% test/control at dose of 16, 10, 4, 2, and 1 mg/kg, respectively | [ | |||
| 4′-Demethoxy-3′,4′-methylenedioxy-methyl rocaglate | 86 | Chloroform | Stem | HT-1080, KB, A431, LNCaP, ZR-75-1, and U373, BCl | 10.0, 6.0, 10.0, 2.0, 2.0, 0.8, 0.9 ng/mL | Antitumor potential of compound was performed with female Balb/c athymic nude mice. Compound significantly inhibited the growth of BC1 cells in culture. The growth of tumor was retarded by treatment with isolated compound during the first 23 days of the study, but after that tumor growth paralleled to the control group | This compound acts by cytostatic mechanism, rather than inducing necrosis or apoptosis. Cells were transiently blocked in the G1/G0 phases of the cycle, and this may be due to inhibition of protein biosynthesis | [ | ||
| 4,5-Didemethylpodophyllotoxin 7′-O-b-D-glucopyranoside | 87 | n-butanol | Roots and rhizomes | Hela, K562, SH-SY5Y and CNE | Compound showed cytotoxicity against four human cancer cell lines | [ | ||||
Ramonanin A Ramonanin B | 88, 89 | Chloroform | Heartwood | MD-MBA 231 | 18 μM | The ramonanins exhibit cytotoxic activity against human breast cancer cell lines with an IC50 value of 18 μM and induce cell death via apoptotic mechanisms | Ramonanin A-treated MD-MBA 231 cells showed characteristic features of apoptotic cell death, which appeared in a time and dose-dependent manner and cell cycle distribution was monitored via flow cytometry using fluorescence-activated cell sorting. It was noted that the ramonanins strongly disrupt cell cycle progression at the G1/S phase transition | [ | ||
Ligraminol A, Ligraminol C, Ligraminol D | 90, 91, 92 | Methanol | Rhizomes | A549, SK-OV-3, SK-MEL-2 | 6.92, 9.44, and 4.53 μM | Compounds showed weak inhibitory activity against various cancerous cell lines. Study has also been performed to check whether the cytotoxicity was selective between tumor and normal cells. For this compounds were evaluated for normal human cell line, HUVEC. This was noted that cytotoxicity of isolated compounds was higher against tumor cells than normal cells. Ligraminol A showed the highest selective cytotoxicity against the SK-MEL-2 cell | [ | |||
| Neglignan H | 93 | Ethyl acetate layer of 70% aqueous acetone | Stem | NB4, A549 and MCF7 | 8.1, 7.4 and 6.7 µM | [ | ||||
| Linderanosides A and B | 94, 95 | Methanolic | Twigs | A549 | 20.86 ± 0.94, 21.85 ± 0.61 µM | [ | ||||
Tiliamuroside, Schizandriside | 96, 97 | Methanolic | Trunk | A549, SK-OV-3, SK-MEL-2, and HCT-15 | 7.32, 8.89, 7.84, and 6.18 μM 6.90, 5.88, 3.26, and 6.65 μM | cytotoxic activity of compounds against the tested cell lines were due to absence of a methoxy group at C-3 in the aryl-tetralin type lignan as indicated by the results | [ | |||
| Pronaphthalide A, Procumbenoside J, 6′-hydroxyl justicidin A, 6′-hydroxyl justicidin B, Tuberculatin | 98, 99, 100, 101, 102 | Ethanol | Whole plants | Human LoVo and BGC-823 | 0.03–10.0 μM, | [ | ||||
| Cleistantoxin | 103 | Dichloromethane | Fruits | KB, MCF-7, MCF-7R | 0.022, 0.036, 0.014 μM | Cleistantoxin had strong activity against KB cells also showed significant activity against MCF-7 and MCF-7R | [ | |||
| Phyllanthusmin D | 104 | Chloroform fraction of methanol extract | Air-dried leaves, twigs, flowers, and fruits | HT-29 | 170 nM | Compound showed activity when tested in an in vivo hollow fiber assay using HT-29 cells implanted in immunodeficient NCr nu/nu mice | 5 μM | Cytotoxic effects of phyllanthusmin D were by inducing tumor cell apoptosis through activation of caspase-3. DNA topoisomerase IIα activity was not inhibited Treatment of HT-29 cells with phyllanthusmin D for 72 h resulted in 28.2% or 30.3% of HT-29 cells undergoing early apoptosis, respectively, | [ | |
| Heilaohulignan C | 105 | 80% ethanol | Roots | HepG-2, BGC-823 and HCT-116 | 9.92, 16.75 and16.59 µM | heilaohulignan C showed good cytotoxicity in HepG-2 cancer cells and weak cytotoxicity against BGC-823 and HCT-116 cancer cells | [ | |||
| (-)-Cubebin | 106 | Acetone | Seeds | A549, K562, SiHa, KB | 8.30 ± 0.16, 8.66 ± 0.43, 8.16 ± 0.41 µM | [ | ||||
| Hedyotol-B | 107 | Ethyl acetate | Stems | SGC7901, A549 | 1.7 ± 0.1 and 6.1 ± 0.5 μM | Hedyotol-B displayed potent inhibitory effect against gastric and lung carcinoma | [ | |||
| Bizanthplanispine A and B, Zanthpodocarpin A and B, Planispine A | 108, 109, 110, 111, 112 | 95% aqueous MeOH | Roots | Hela, HL-60, PC-3 | Bizanthplanispine A and B, zanthpodocarpin A and B showed significant reduction in the proliferation of Hela with IC50 values ranging from 15.00 to 26.44 µg/mL. Planispine A showed the strongest inhibition on the growth of HL-60 and PC-3 with IC50 values of 4.90 and 23.45 µg/mL | All isolated compounds showed inhibitory effect on different cancer cell lines | [ |
L5178Y, leukemia mouse lymphoma cells; MCF-7, breast cancer cell lines; HCT116, human colon carcinoma cell lines; P-388, leukemia cancer cells; SK-BR-7, breast cancer cells; MDA-MB-231, breast cancer cells; MDA-MB-435s, breast cancer cells; LNCaP, prostate cancer cells; COC1, ovarian cancer cells; K562, human chronic myeloid leukemia; HT1080, human fibrosarcoma cells; KB16, human epidermoid carcinoma cells; HT-29 human colorectal adenocarcinoma cell line; A549, human lung cancer cell line; SK-Mel-2, human skin melanoma cell lines; B16F1, mouse melanoma cell lines; Col-2, human colon cancer cell lines; Lu-1, lung adenocarcinoma cell line; HL-60, human acute promyelocytic leukemia cell line; Hep-G2, human hepatocellular carcinoma; R-Hep-G2, human resistant hepatoma; Bel-7402, hepatocellular carcinoma; Hep-2 alveolar epithelial carcinoma cell line; EAhy926, human umbilical vein cell line; HeLa, human uterine cervix carcinoma cell lines; L929, murine fibroblast cell line; RAW 264.7, murine macrophage cell line; HCT-15, human colorectal carcinoma cell line; SW480, colon carcinoma cells; JB6, murine epidermal cells; CCRFCEM, leukemia cell lines; K-526, leukemia cell lines; MOLT-4, leukemia cell lines; RPMI-8226, leukemia cell lines; SMMC-7721, human hepatoma cell line; V79, hamster lung fibroblast cell; B16, mouse melanoma cell; M12.C3.F6, murine cancer cell line (macrophages transformed by virus Abelson leukemia); MDA-MB-468, breast cancer cell lines; P3X63-Ag8.653, murine myeloma cell line; AGS, gastric cancer cell lines; MIA-PaCa, pancreatic carcinoma cell line; SMMC-7721, human hepatoma cells; HER2, negative breast cancer cell line; MDA-MB-231, triple negative breast cancer cell line; MEL-28, melanoma cell lines; HT-low, Human fibrosarcoma cells; KB, human oral epidermoid carcinoma; A43l, human epidermoid carcinoma; ZR-75–1, human hormone-dependent breast cancer; U373, human glioblastoma cell lines; BCl, human breast cancer; SH-SY5Y, neuroblastoma cell line; CNE, nasopharyngeal carcinoma; SK-OV-3, ovary malignant ascites; NB4, human acute promyelocytic leukemia cell line; MCF-7R, human breast cancer cell line; SiHa, human cervical carcinoma; SGC7901, human gastric carcinoma; PC-3, human prostate carcinoma cells; SCLC, small-cell lung cancer